ACS Study Finds Worsening Survival Disparities by Health Insurance and Race Among Women With Breast Cancer

Immune checkpoint inhibitors (ICIs)—drugs that take the “brakes” off immune cells—have transformed cancer care. But they’re far from perfect: most patients don’t respond because their tumors are “cold,” meaning the immune system isn’t paying attention.

A University of Colorado Cancer Center leader co-chaired an international expert panel that drafted new global guidelines for conducting geriatric assessments of older people with cancer in parts of the world where robust medical resources may be lacking.

Men’s Breast Cancer Awareness Week, observed Oct. 17-23, shines a light on a lesser-known truth: Men can get breast cancer too. Early detection saves lives, yet symptoms like lumps or skin changes are often overlooked.

After being diagnosed with stage 3 triple-negative breast cancer the day after her 29th birthday, Meagan Pettit underwent chemotherapy, a bilateral mastectomy, radiation and reconstruction.